Multispecialty groups have emerged as a proven approach to better patient outcomes while creating cost efficiencies for providers. This session will explore the benefits of developing and optimizing a multispecialty practice, from coordinated care pathways and shared resources to enhanced patient access and improved quality metrics. Attendees will gain insight into strategies that support clinical collaboration across specialties and streamline operations to drive both savings and sustainability.

This panel will bring together experts in health economics and clinical wound management to explore how expanding access to care and strengthening patient resources can transform outcomes. The discussion will highlight the interplay between wound care costs and comorbidities, examine the systemic barriers patients face in receiving comprehensive treatment, and showcase models of care that have successfully reduced costs through early intervention and improved patient support.

Are treatment options limited by geography? 

Join Dr. Morrison, wound care specialist, and Dr. Liden, podiatric surgeon, as they detail a collaborative interstate effort to save the limbs of patients with severe Charcot arthropathy utilizing advanced surgical techniques, CAMPs, hyperbaric oxygen, and shared decision making. 

Speaker: Dr. Andrew Pavelescu  

Title: From Trial to Treatment: STABLECAMP’s Role in Modernizing Wound Care through a Modified Multi-Platform RCT"

The STABLECAMP trial is a multicenter, prospective, randomized controlled study evaluating the treatment of non-healing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). STABLECAMP uses a modified multi-platform (Matriarch) design to compare the results of treating these wounds through standard of care (SOC) combined with multiple cellular, acellular, and matrix-like products (CAMPs) versus SOC alone. This adaptive platform enables comparative analysis across diverse graft technologies and supports the inclusion of additional CAMPs over time.

Speaker: Dr. Neil Sandhu  

Title: Amnio Tri-Core Graft Enhances Post-Mohs Wound Healing: A Retrospective Analysis in Non-Melanoma Skin Cancer Patients

Retrospective analysis reveals Amnio Tri-Core graft accelerates healing after Mohs surgery, with biologic mechanisms supporting tissue regeneration and infection control.

This inspiring panel session will look at the careers of pioneering women working in the field of wound care. They will share the challenges they faced, tips for those who want to advance their careers in wound care and the opportunities there are for women to shape the future of the field

Join us for an engaging session that delves into the dynamic world of mobile wound care, where healthcare professionals navigate the challenges and triumphs of providing quality treatment on the go. This interactive discussion will feature firsthand accounts from practitioners who have experienced remarkable successes and unexpected setbacks in diverse settings, from urban environments to rural landscapes.

Artificial intelligence is rapidly emerging as a powerful tool in wound care, with the potential to streamline documentation, enhance imaging, and improve the accuracy of wound measurement. This panel discussion brings together experts at the intersection of technology and clinical practice to explore how AI-driven solutions are being developed and integrated into care pathways.

This case study-based session will explore the challenges of managing atypical and hard-to-heal wounds, where conventional approaches often prove inadequate. Attendees will gain practical insights into the application of cutting-edge approaches and see how innovative therapies can overcome barriers to healing.

Join us for a closing session that distils the key insights, decisions, and collaborative goals emerging from the 2025 IPAWS & Tissue Repair Summit.

This session will highlight the most impactful discussions, outline priority initiatives for the year ahead, and define actionable steps to advance innovation, partnerships, and clinical translation in 2026.